Group One Trading
EDIT icon

Group One Trading’s Editas Medicine EDIT Stock Holding History

Group One Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4K Sell
10,700
-73,300
-87% -$155K ﹤0.01% 5776
2025
Q4 		$172K Buy
84,000
+62,700
+294% +$181K ﹤0.01% 4515
2025
Q3 		$73.9K Sell
21,300
-2,600
-11% -$7.26K ﹤0.01% 5612
2025
Q2 		$52.6K Sell
23,900
-24,800
-51% -$40.6K ﹤0.01% 5538
2025
Q1 		$56.5K Buy
48,700
+9,300
+24% +$13.7K ﹤0.01% 5069
2024
Q4 		$50K Buy
39,400
+14,000
+55% +$35.7K ﹤0.01% 5056
2024
Q3 		$86.6K Sell
25,400
-2,300
-8% -$10K ﹤0.01% 4292
2024
Q2 		$129K Buy
27,700
+19,900
+255% +$112K ﹤0.01% 3749
2024
Q1 		$57.9K Sell
7,800
-49,900
-86% -$415K ﹤0.01% 4597
2023
Q4 		$585K Buy
57,700
+43,300
+301% +$380K ﹤0.01% 2936
2023
Q3 		$112K Buy
14,400
+1,100
+8% +$9.43K ﹤0.01% 4347
2023
Q2 		$109K Buy
13,300
+8,000
+151% +$69.7K ﹤0.01% 4519
2023
Q1 		$38.4K Sell
5,300
-53,900
-91% -$479K ﹤0.01% 5046
2022
Q4 		$525K Buy
59,200
+26,900
+83% +$295K ﹤0.01% 3000
2022
Q3 		$395K Sell
32,300
-1,300
-4% -$20.3K ﹤0.01% 3467
2022
Q2 		$397K Sell
33,600
-15,800
-32% -$212K ﹤0.01% 3641
2022
Q1 		$940K Sell
49,400
-11,400
-19% -$212K ﹤0.01% 3145
2021
Q4 		$1.61M Sell
60,800
-184,600
-75% -$6.35M ﹤0.01% 2839
2021
Q3 		$10.1M Buy
245,400
+69,700
+40% +$3.82M 0.01% 1061
2021
Q2 		$9.95M Sell
175,700
-110,400
-39% -$4.08M 0.01% 1081
2021
Q1 		$12M Buy
286,100
+15,800
+6% +$900K 0.02% 819
2020
Q4 		$19M Buy
270,300
+239,100
+766% +$9.82M 0.03% 472
2020
Q3 		$875K Sell
31,200
-25,100
-45% -$817K ﹤0.01% 2321
2020
Q2 		$1.67M Sell
56,300
-108,700
-66% -$2.84M 0.01% 1606
2020
Q1 		$3.27M Sell
165,000
-49,500
-23% -$1.25M 0.03% 744
2019
Q4 		$6.35M Buy
214,500
+127,100
+145% +$3.17M 0.04% 543
2019
Q3 		$1.99M Buy
87,400
+31,700
+57% +$785K 0.02% 1227
2019
Q2 		$1.38M Sell
55,700
-345,600
-86% -$8.25M 0.01% 1362
2019
Q1 		$9.81M Buy
401,300
+376,800
+1,538% +$8.53M 0.11% 204
2018
Q4 		$557K Sell
24,500
-12,000
-33% -$327K ﹤0.01% 1920
2018
Q3 		$1.16M Sell
36,500
-3,700
-9% -$120K 0.01% 1586
2018
Q2 		$1.44M Sell
40,200
-800
-2% -$28.3K 0.01% 1377
2018
Q1 		$1.36M Buy
41,000
+22,500
+122% +$802K 0.01% 1277
2017
Q4 		$569K Buy
18,500
+2,400
+15% +$60.4K ﹤0.01% 2146
2017
Q3 		$387K Sell
16,100
-33,200
-67% -$632K ﹤0.01% 2278
2017
Q2 		$827K Sell
49,300
-1,800
-4% -$32.4K 0.01% 1603
2017
Q1 		$1.14M Buy
51,100
+45,900
+883% +$951K 0.01% 1259
2016
Q4 		$84K Sell
5,200
-1,500
-22% -$22.8K ﹤0.01% 2943
2016
Q3 		$90K Buy
+6,700
New +$137K ﹤0.01% 2988

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Group One Trading's EDIT Position: Q1 2026 in Review

Group One Trading opened a new position in Editas Medicine (EDIT) in Q1 2026: 22,309 shares worth $55.1K. The stake represents ﹤0.01% of the portfolio and ranks #5193 among its holdings. This is a return to the name: Group One Trading previously reported a position in EDIT as recently as Q2 2025.

Group One Trading first reported a position in EDIT in Q3 2016 and has held it in 26 quarters since. The position peaked at $4.43M in Q2 2021. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Group One Trading held 22,309 shares of Editas Medicine worth $55.1K as of Q1 2026.
  • Editas Medicine was a new Group One Trading position in Q1 2026.
  • Editas Medicine made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5193 holding.
  • Group One Trading first reported a position in Editas Medicine in Q3 2016 and has held it in 26 quarters since.
  • Group One Trading's Editas Medicine position peaked at $4.43M in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.